Why Mold Is an Inflammatory — Not an Allergic — Illness

For a century, medicine has filed mold under “allergy.” For the sickest patients, that single filing sends doctors toward the wrong tests and the wrong treatments.

The allergic model — real, but incomplete

The allergic picture is familiar: IgE antibodies, mast cells, histamine, skin-prick tests, antihistamines. It is genuine — some people truly are allergic to mold spores. But it does not explain the multi-system, energy-crashing illness that follows a water-damaged building.

The inflammatory model

In mold illness, the toxins and biological fragments act as danger signals to the innate immune system — the ancient, first-responder branch. They trip the same pattern-recognition receptors that detect serious bacterial infection, driving body-wide inflammation rather than an allergic reaction.

The shift from the allergic model to the inflammatory model is not a refinement of the same paradigm. It is a fundamental reconceptualization of what mold does to the body and why. — Andrew Heyman, MD

Different tests, different treatments

The two models look at different markers — specific IgE for allergy, versus inflammatory and regulatory markers like TGF-β1, MMP-9, C4a, and GDF15 for the inflammatory illness — and they call for different treatments. Reaching for antihistamines when the problem is innate inflammation is one of the most common, and most consequential, mistakes in the field.

Why you react in “clean” places, too

The inflammatory model also explains something allergy cannot: why patients keep reacting in buildings with no water damage, and stay inflamed after remediation. The innate system can be “trained” to a heightened baseline — a lingering setting, not a fresh allergy.

If you have been worked up for allergies and told everything is normal, it may be that the wrong system was tested.